Botulinum A toxin injections into the detrusor: An effective treatment in idiopathic and neurogenic detrusor overactivity?

Neurourology and Urodynamics

Volumn 24, Issue 3, 2005, Pages 231-236

  Kessler, Thomas M ^a   Danuser, Hansjörg ^a   Schumacher, Martin ^a   Studer, Urs E ^a   Burkhard, Fiona C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Botulinum A toxin; Idiopathic detrusor overactivity; Injections into the detrusor; Neurogenic detrusor overactivity

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; TOLTERODINE; TROSPIUM CHLORIDE;

ADULT; AGED; ARTICLE; BLADDER; CLINICAL ARTICLE; CYSTOMETRY; DETRUSOR MUSCLE; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; NEUROGENIC BLADDER; OVERACTIVE BLADDER; PROSPECTIVE STUDY; URINE FLOW RATE; URODYNAMICS;

ADULT; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INCONTINENCE PADS; MALE; MIDDLE AGED; MUSCLE HYPERTONIA; MUSCLE, SMOOTH; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; URINARY INCONTINENCE; URODYNAMICS;

EID: 18144368897     PISSN: 07332467     EISSN: None     Source Type: Journal    
DOI: 10.1002/nau.20105     Document Type: Article

References (19)

1. Abrams P, Cardozo L, Fall M, et al. 2002. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167-78.
2. Chancellor MB, O'Leary M, Erickson J, et al. 2003. Successful use of bladder botulinum toxin injection to treat refractory overactive bladder. J Urol Suppl 169:351 [Abstract DP350].
3. Harper M, Fowler CJ, Dasgupta P. 2004. Botulinum toxin and its applications in the lower urinary tract. BJU Int 93:702-6.
4. Kuo HC. 2004. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63:868-72.
5. Leippold T, Reitz A, Schurch B. 2003. Botulinum toxin as a new therapy option for voiding disorders: Current state of the art. Eur Urol 44:165-74.
6. Loch A, Loch T, Osterhage J, et al. 2003. Botulinum-A toxin detrusor injections in the treatment of non-neurologic and neurologic cases of urge incontinence. Eur Urol Suppl 2:172 [Abstract 678].
7. Pistolesi D, Selli C, Rossi B, et al. 2004. Botulinum toxin type B for type A resistant bladder spasticity. J Urol 171:802-3.
8. Radziszewski P, Borkowski A. 2002. Botulinum toxin type A intravesical injections for instable bladder overactivity. Eur Urol Suppl 1:134 [Abstract 526].
9. Rapp DE, Lucioni A, Katz EE, et al. 2004. Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: An initial experience. Urology 63:1071-5.
10. Reitz A, Schurch B. 2004. Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity. J Urol 171:804; discussion 804-5.
11. Reitz A, Stöhrer M, Kramer G, et al. 2004. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510-5.
12. Riccabona M, Koen M, Schindler M, et al. 2004. Botulinum-A toxin injection into the detrusor: A safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845-8; discussion 848.
13. Schmid DM, Schurch B, John H, et al. 2004. Botulinum toxin injections to treat overactive bladder. Eur Urol Suppl 3:131 [Abstract 516].
14. Schulte-Baukloh H, Michael T, Schobert J, et al. 2002. Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomenin-gocele: Preliminary results. Urology 59:325-7; discussion 327-8.
15. Schulte-Baukloh H, Michael T, Sturzebecher B, et al. 2003. Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139-43.
16. Schurch B, Schmid DM, Stöhrer M. 2000a. Treatment of neurogenic incontinence with botulinum toxin A. N Engl J Med 342:665.
17. Schurch B, Stöhrer M, Kramer G, et al. 2000b. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692-7.
18. Schäfer W, Abrams P, Liao L, et al. 2002. Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21:261-74.
19. Smith CP, Chancellor MB. 2004. Emerging role of botulinum toxin in the management of voiding dysfunction. J Urol 171:2128-37.